NIDA to Fund Small Businesses Developing Modified RNA Tools | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute on Drug Abuse plans to commit $2 million in Fiscal Year 2015 to spur small businesses to development of new tools for monitoring and manipulating covalently modified eukaryotic mRNAs and regulatory RNAs, NIDA said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.